Evidence map›Paper›PMID 33572115›Full record

ArticleInternational journal of molecular sciences2021

The Effect of Neddylation Inhibition on Inflammation-Induced MMP9 Gene Expression in Esophageal Squamous Cell Carcinoma.

Anita Hryniewicz-Jankowska, Jaroslaw Wierzbicki, Renata Tabola, Kamilla Stach, Khalid Sossey-Alaoui, Katarzyna Augoff

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Anita Hryniewicz-JankowskaLaboratory of Cytobiochemistry, Biotechnology Faculty, University of Wroclaw, 50-383 Wroclaw, Poland.
Jaroslaw WierzbickiDepartment of Minimally Invasive Surgery and Proctology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Renata TabolaSecond Department and Clinic of General and Oncological Surgery, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Kamilla StachDepartment of Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Khalid Sossey-AlaouiDepartment of Medicine, School of Medicine, Case Western Reserve University, Rammelkamp Center for Research, Cleveland, OH 44109, USA.
Katarzyna AugoffDepartment of Surgical Education, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Wroclaw Medical University · PLCase Western Reserve University · USUniversity of Wrocław · PL

Funding

TNBC in AA WomenR01CA226921 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SOSSEY-ALAOUI, KHALID · 2019 to 2023
$2.3M
NCI NIH HHS R01 CA226921The National Science Centre, Poland Grant 2017/25/B/NZ5/01251
6 · The paper itself

Abstract

Inhibition of the protein neddylation process by the small-molecule inhibitor MLN4924 has been recently indicated as a promising direction for cancer treatment. However, the knowledge of all biological consequences of MLN4924 for cancer cells is still incomplete. Here, we report that MLN4924 inhibits tumor necrosis factor-alpha (TNF-α)-induced matrix metalloproteinase 9 (MMP9)-driven cell migration. Using real-time polymerase chain reaction (PCR) and gelatin zymography, we found that MLN4924 inhibited expression and activity of MMP9 at the messenger RNA (mRNA) and protein levels in both resting cells and cells stimulated with TNF-α, and this inhibition was closely related to impaired cell migration. We also revealed that MLN4924, similar to TNF-α, induced phosphorylation of inhibitor of nuclear factor kappa B-alpha (IκB-α). However, contrary to TNF-α, MLN4924 did not induce IκB-α degradation in treated cells. In coimmunoprecipitation experiments, nuclear IκB-α which formed complexes with nuclear factor kappa B p65 subunit (NFκB/p65) was found to be highly phosphorylated at Ser32 in the cells treated with MLN4924, but not in the cells treated with TNF-α alone. Moreover, in the presence of MLN4924, nuclear NFκB/p65 complexes were found to be enriched in c-Jun and cyclin dependent kinase inhibitor 1 A (CDKN1A/p21) proteins. In these cells, NFκB/p65 was unable to bind to the MMP9 gene promoter, which was confirmed by the chromatin immunoprecipitation (ChIP) assay. Taken together, our findings identified MLN4924 as a suppressor of TNF-α-induced MMP9-driven cell migration in esophageal squamous cell carcinoma (ESCC), likely acting by affecting the nuclear ubiquitin-proteasome system that governs NFκB/p65 complex formation and its DNA binding activity in regard to the MMP9 promoter, suggesting that inhibition of neddylation might be a new therapeutic strategy to prevent invasion/metastasis in ESCC patients.

Indexed as

Cell Line, TumorCell MovementCyclopentanesEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaGene Expression Regulation, NeoplasticHumansMatrix Metalloproteinase 9NEDD8 ProteinNeoplasm InvasivenessNF-KappaB Inhibitor alphaPhosphorylationPromoter Regions, GeneticProtein Processing, Post-TranslationalPyrimidinesTranscription Factor RelACyclopentanesMatrix Metalloproteinase 9MMP9 protein, humanNAE protein, humanNEDD8 ProteinNEDD8 protein, humanNF-KappaB Inhibitor alphaNFKBIA protein, humanpevonedistatPyrimidinesRELA protein, humanTNF protein, humanTranscription Factor RelATumor Necrosis Factor-alphaUbiquitin-Activating Enzymescancer cell migrationesophageal squamous cell carcinomametalloproteinasesneddylationTNF-α–NFκB signaling pathway

Identifiers

PMID33572115
PMCPMC7915196
OpenAlexW3128597224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.